← Back to Search

Treatment for Heart Failure (DETECT-HF Trial)

N/A
Recruiting
Research Sponsored by Cordio Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up eos is defined as when a total of at least 78 first usable and cec-adjudicated hfes have occurred or up-to 24 months per patient
Awards & highlights

Summary

Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~eos is defined as when a total of at least 78 first usable and cec-adjudicated hfes have occurred or up-to 24 months per patient
This trial's timeline: 3 weeks for screening, Varies for treatment, and eos is defined as when a total of at least 78 first usable and cec-adjudicated hfes have occurred or up-to 24 months per patient for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Heart Failure Events (HFEs)

Find a Location

Who is running the clinical trial?

Cordio MedicalLead Sponsor
5 Previous Clinical Trials
887 Total Patients Enrolled
4 Trials studying Heart Failure
845 Patients Enrolled for Heart Failure
Ronit Haviv, PhDStudy DirectorCordio Medical
1 Previous Clinical Trials
250 Total Patients Enrolled
1 Trials studying Heart Failure
250 Patients Enrolled for Heart Failure
~140 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top